Literature DB >> 3982225

D-2 dopamine receptors in the frontal cortex of rat and human.

D R Liskowsky, L T Potter.   

Abstract

D-2 dopamine receptors and serotonin receptors in the frontal cortex of rat and human were labelled with 3H-spiroperidol. The D-2 receptors were then distinguished in 4 ways. Dissociation of spiroperidol was biphasic, indicating two populations of sites. Cinanserin in competition with 3H-spiroperidol exhibited high (75%) and low (25%) affinity sites. Dopamine and LY 141865 in competition with 1.25 nM 3H-spiroperidol exhibited high (20-25%) and low (80-75%) affinity sites in the absence of cinanserin, while in the presence of 300 nM cinanserin only the high affinity sites remained. Lesioning of the dopaminergic meso-cortical pathway increased the number of cinanserin-resistant sites by 26%. Thus 3H-spiroperidol binding in the presence of cinanserin can be used to selectively label D-2 receptors in the frontal cortex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3982225     DOI: 10.1016/0024-3205(85)90379-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride.

Authors:  M S Lidow; P S Goldman-Rakic; P Rakic; R B Innis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients.

Authors:  R C Arora; H Y Meltzer
Journal:  J Neural Transm Gen Sect       Date:  1991

3.  Bacterial artificial chromosome transgenic analysis of dynamic expression patterns of regulator of G-protein signaling 4 during development. I. Cerebral cortex.

Authors:  P J Ebert; D B Campbell; P Levitt
Journal:  Neuroscience       Date:  2006-09-25       Impact factor: 3.590

4.  Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.

Authors:  Daniel B Campbell; Philip J Ebert; Tara Skelly; T Scott Stroup; Jeffrey Lieberman; Pat Levitt; Patrick F Sullivan
Journal:  Biol Psychiatry       Date:  2007-06-22       Impact factor: 13.382

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.